Showing results (181-190 of 268) with videos related to
Sort By:
Pageof 27
Antiviral Therapy|May 15, 2002
Response to antiretroviral therapy among patients exposed to three classes of antiretrovirals: results from the EuroSIDA studyA Mocroft, A N Phillips, N Friis-Møller, et al.Journal of Viral Hepatitis|January 29, 2008
Liver fibrosis on account of chronic hepatitis C is more severe in HIV-positive than HIV-negative patients despite antiretroviral therapyV de Lédinghen, P Barreiro, J Foucher, et al.European Journal of Cancer. Part B, Oral Oncology|July 1, 1993
Adenomatoid odontogenic tumour with features of calcifying epithelial odontogenic tumour. (The so-called combined epithelial odontogenic tumour.) Clinico-pathological report of 12 casesC Montes Ledesma, A Mosqueda Taylor, E Romero de León, et al.AIDS (London, England)|July 14, 1998
Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in SpainM Gómez-Cano, A Rubio, T Puig, et al.Journal of Medical Virology|July 14, 1998
Prevalence and genotypes of GB virus C/hepatitis G virus (GBV-C/HGV) and hepatitis C virus among patients infected with human immunodeficiency virus: evidence of GBV-C/HGV sexual transmissionA Ibáñez, M Giménez-Barcons, A Tajahuerce, et al.AIDS Research and Human Retroviruses|December 2, 1999
Resistance of the human immunodeficiency virus to the inhibitory action of negatively charged albumins on virus binding to CD4C Cabrera, M Witvrouw, A Gutiérrez, et al.Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|September 10, 1998
Efficacy of adding indinavir to previous reverse transcriptase nucleoside analogues in relation to genotypic and phenotypic resistance development in advanced HIV-1-infected patientsL Ruiz, M Nijhuis, C Boucher, et al.HIV Medicine|April 27, 2011
Lipid profiles for nevirapine vs. atazanavir/ritonavir, both combined with tenofovir disoproxil fumarate and emtricitabine over 48 weeks, in treatment-naïve HIV-1-infected patients (the ARTEN study)Daniel Podzamczer, J Andrade-Villanueva, B Clotet, et al.HIV Medicine|December 22, 2015
Biological markers of fertility (inhibin-B) in HIV-infected men: influence of HIV infection and antiretroviral therapyO Moreno-Pérez, V Boix, E Merino, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 26, 1999
Usefulness of pp65 antigenemia for the early diagnosis of cytomegalovirus disease in patients with AIDSD Torrús, J Portilla, I Hernández-Aguado, et al.Pageof 27